SCHEMBL12436016

SCHEMBL12436016

CCC(=O)Nc1cc(S(=O)(=O)Nc2ccc(OC)c(OC)c2)cc(F)c1CO

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
HTT P42858 3/20 0.51
ALOX15 P16050 1/20 0.51
MAPK1 P28482 1/20 0.51
NPSR1 Q6W5P4 2/20 0.50
KMT2A Q03164 5/20 0.47
ALDH1A1 P00352 5/20 0.47
MEN1 O00255 4/20 0.47
PKM P14618 1/20 0.47
TSHR P16473 1/20 0.47
HDAC1 Q13547 3/20 0.46
HDAC4 P56524 1/20 0.44
EGFR P00533 2/20 0.43
ERBB4 Q15303 2/20 0.43
ERBB2 P04626 1/20 0.43
HIF1A Q16665 1/20 0.42
GAA P10253 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12436015 0.82 LMNA (0.62) LMNASMN1; SMN2HTTALOX15MAPK1
SCHEMBL2219490 0.76 SMN1; SMN2 (0.59) LMNASMN1; SMN2HTTALOX15MAPK1
SCHEMBL6680695 0.75 LMNA (0.70) LMNASMN1; SMN2HTTALOX15MAPK1
SCHEMBL12436008 0.75 SMN1; SMN2 (0.56) LMNASMN1; SMN2HTTALOX15MAPK1
SCHEMBL12436017 0.74 SMN1; SMN2 (0.63) LMNASMN1; SMN2HTTALOX15MAPK1
SCHEMBL2218687 0.73 SMN1; SMN2 (0.59) LMNASMN1; SMN2HTTALOX15MAPK1
SCHEMBL12512681 0.72 SMN1; SMN2 (0.43) SMN1; SMN2HTTNPSR1ALDH1A1TSHR
SCHEMBL12435989 0.72 SMN1; SMN2 (0.58) LMNASMN1; SMN2HTTALOX15MAPK1
SCHEMBL3970414 0.71 SMN1; SMN2 (0.68) LMNASMN1; SMN2NPSR1KMT2AALDH1A1
SCHEMBL12435993 0.71 LMNA (0.47) LMNASMN1; SMN2MAPK1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110178108-A1 Group of amino substituted benzoyl derivatives and their preparation and their use Institute of Medicinal Biotechnology Academy of Medical Science (CN) 2011-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110178108-A1 Group of amino substituted benzoyl derivatives and their preparation and their use CUL3, APOBEC3G, BRPF3 LMNA 2812/4885SMN1; SMN2 4598/4885HTT 1248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.